drugset / Trial / NCT06170723
A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This 2-part study will evaluate the effect of coadministration of a Cytochrome P450, family 3, subfamily A (CYP3A) inhibitor, itraconazole (Part 1), and a high-fat/high-calorie meal and a modified gastric pH (Part 2), on the single dose drug levels of BMS-986368 in healthy participants.
Timeline
- Start
- 2024-03-18
- Primary completion
- 2024-05-25
- Completion
- 2024-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986368 | Unknown | — | — |
| Subject | Famotidine | Other / unclassified | — | — |
| Subject | Itraconazole | Small molecule | — | — |
Indications
No indication recorded.